DEF 14A: Safety Shot, Inc. Seeks Stockholder Approval for Director Re-election, Auditor Ratification, Equity Incentive Plan, and Share Increase

Safety Shot, Inc. is holding its 2024 Annual Meeting of Stockholders to vote on key proposals including director re-election, auditor ratification, an equity incentive plan, and an increase in authorized common stock.

Summary

• Safety Shot, Inc. is convening its 2024 Annual Meeting of Stockholders on July 31, 2024, to address several key proposals.
• Stockholders will vote on the re-election of six directors to the Board of Directors.
• The meeting will also include a vote to ratify the appointment of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• A proposal to ratify the 2024 Equity Incentive Plan, which includes the reservation of 15,000,000 shares of common stock, will be presented.
• Stockholders will also vote on an amendment to the company's Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 100,000,000 to 250,000,000 shares.
• The Board of Directors recommends voting in favor of all director nominees and proposals.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The proposals are routine and the Board recommends voting in favor of all of them, suggesting a positive outlook on the company's governance and future plans.

Positives

• The proposed increase in authorized shares provides the company with greater flexibility for future corporate actions, including strategic investments and equity-based financing.
• The ratification of an equity incentive plan helps attract, motivate, and retain key personnel.
• The board is committed to actively seeking highly qualified women and individuals from minority groups and the LGBTQ+ community to include in the pool from which new candidates are selected.

Negatives

• Approving the Share Increase Proposal will not result in any dilution to current stockholders unless and until the Company issues such additional shares in the future.
• The future issuance of additional shares of Common Stock (other than a stock split or dividend) would have the effect of diluting the voting rights and could have the effect of diluting earnings per share and book value per share of existing stockholders.

Risks

• Failure to secure stockholder approval for the proposed increase in authorized shares could limit the company's ability to raise capital or pursue strategic opportunities.
• Future issuances of common stock could dilute existing shareholders' voting rights and earnings per share.
• The company's success depends on its ability to attract and retain qualified personnel, and the equity incentive plan may not be sufficient to achieve this.

Future Outlook

The company aims to use the increased authorized shares for general corporate purposes, including strategic investments, partnerships, and employee equity incentives, to support its business strategies.

Management Comments

• The Board recommends that you vote for each of the director nominees included in Proposal No. 1, and for Proposal No. 2, No. 3 and No. 4.

Industry Context

The proposals reflect standard corporate governance practices, including seeking stockholder approval for key decisions such as director elections, auditor ratification, and equity incentive plans, which are common in publicly traded companies.

Comparison to Industry Standards

• The structure of the board committees (Audit, Compensation, and Nominating and Corporate Governance) aligns with standard corporate governance practices observed in publicly listed companies.
• The director independence criteria, referencing Nasdaq listing standards, are consistent with industry norms for ensuring board objectivity.
• The process for selecting and ratifying the independent auditor is a common practice among publicly traded companies to ensure audit quality and independence.

Related Party Transactions

• At December 31, 2022, the Company had invested $2,908,300 in Jupiter Wellness Sponsor LLC (JWSL), a limited liability company formed for the purpose of sponsorship of Jupiter Wellness Acquisition Corp. (JWAC), a special purpose acquisition company (SPAC) and a unconsolidated subsidiary.
• Mr. Brian John, our CEO, was the managing member of JWSL and Chief Executive Officer of JWAC.
• On March 1, 2024, the Company entered into a transition advisory agreement (the Agreement) with Brian S. John, pursuant to which the Mr. John resigned from his position as the Chief Executive Officer of the Company and was hired as an advisor to the Company for a term of 3 months ending on June 1, 2024, and a further 3 months extension with the mutual consent of the parties therein.
• Mr. John shall receive $12,500 as a monthly compensation for his services under the Agreement.

Stakeholder Impact

• Approval of the proposals will enable the company to pursue its strategic objectives, potentially benefiting shareholders through increased value.
• The equity incentive plan is designed to align the interests of management and employees with those of shareholders.
• The ratification of the auditor ensures the integrity of the company's financial reporting, which is important for investor confidence.

Next Steps

• Stockholders are encouraged to review the proxy statement and vote on the proposals.
• The company will hold the Annual Meeting on July 31, 2024, to discuss and vote on the proposals.

Key Dates

Keywords

proxy statement, annual meeting, Safety Shot Inc., directors, stockholders, equity incentive plan, authorized shares, M&K CPAS, ratification, common stock